Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE) Trading Down 1.4% – Should You Sell?

Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE) shares dropped 1.4% during trading on Thursday . The company traded as low as $86.00 and last traded at $86.89. Approximately 57,653 shares were traded during trading, an increase of 8% from the average daily volume of 53,629 shares. The stock had previously closed at $88.15.

Direxion Daily Healthcare Bull 3x Shares Price Performance

The business’s 50 day simple moving average is $95.65 and its 200 day simple moving average is $104.47. The stock has a market cap of $134.68 million, a P/E ratio of 20.81 and a beta of 1.72.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC raised its stake in shares of Direxion Daily Healthcare Bull 3x Shares by 16.2% in the second quarter. EverSource Wealth Advisors LLC now owns 2,150 shares of the company’s stock valued at $169,000 after acquiring an additional 300 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Direxion Daily Healthcare Bull 3x Shares in the second quarter valued at approximately $34,000. Frazier Financial Advisors LLC bought a new position in shares of Direxion Daily Healthcare Bull 3x Shares in the fourth quarter valued at approximately $112,000. Qube Research & Technologies Ltd bought a new position in shares of Direxion Daily Healthcare Bull 3x Shares in the second quarter valued at approximately $157,000. Finally, Onyx Bridge Wealth Group LLC bought a new position in shares of Direxion Daily Healthcare Bull 3x Shares in the third quarter valued at approximately $206,000.

About Direxion Daily Healthcare Bull 3x Shares

The Direxion Daily Healthcare Bull 3X Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is managed by Direxion.